Thomas Chen Net Worth

11 Nov People

The estimated Net Worth of Thomas F Chen is at least $13.8 Million dollars as of 10 February 2010. Mr. Chen owns over 38,221 units of Baxter International stock worth over $9,923,209 and over the last 14 years he sold BAX stock worth over $3,537,469. In addition, he makes $297,941 as Independent Director at Baxter International.

Mr. Chen BAX stock SEC Form 4 insider trading

Thomas has made over 22 trades of the Baxter International stock since 2006, according to the Form 4 filled with the SEC. Most recently he exercised 38,221 units of BAX stock worth $2,013,864 on 10 February 2010.

The largest trade he’s ever made was exercising 49,646 units of Baxter International stock on 7 August 2007 worth over $2,076,196. On average, Thomas trades about 3,737 units every 14 days since 2006. As of 10 February 2010 he still owns at least 126,507 units of Baxter International stock.

You can see the complete history of Mr. Chen stock trades at the bottom of the page.

Thomas Chen biography

Thomas F. Chen is an Independent Director of the Company. Mr. Chen served as Senior Vice President and President of International Nutrition of Abbott Laboratories (Abbott) before retiring in 2010. During his 22-year career at Abbott, Mr. Chen served in a number of roles with expanding responsibilities, primarily in Pacific/Asia/Africa where he oversaw expansion into emerging markets. Prior to Abbott, he held several management positions at American Cyanamid Company, which later merged with Pfizer Inc. Mr. Chen currently serves as a director of Stericycle, Inc. Mr. Chen previously served as a director of Cyanotech Corporation.

What is the salary of Thomas Chen?

As the Independent Director of Baxter International, the total compensation of Thomas Chen at Baxter International is $297,941. There are 12 executives at Baxter International getting paid more, with Jose Almeida having the highest compensation of $15,645,100.

How old is Thomas Chen?

Thomas Chen is 69, he’s been the Independent Director of Baxter International since 2012. There are 4 older and 15 younger executives at Baxter International. The oldest executive at Baxter International, Inc. is James Gavin, 73, who is the Independent Director.

What’s Thomas Chen’s mailing address?

Thomas’s mailing address filed with the SEC is 73-4460 QUEEN KAAHUMANU HWY #102, , KAILUA-KONA, HI, 96740.

Insider trading at Baxter International

Over the last 17 years, insiders at Baxter International have traded over $959,173,302 worth of Baxter International stock and bought 168,447 units worth $5,457,676 . The most active insider traders include Point Llc Loeb Daniel S Third, Michael F Mahoney, and Robert L Jr Parkinson. On average, Baxter International executives and independent directors trade stock every 34 days with the average trade being worth of $8,164,997. The most recent stock trade was executed by Andrew Frye on 14 October 2019, trading 3,332 units of BAX stock currently worth $293,216.

What does Baxter International do?

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

What does Baxter International’s logo look like?

Complete history of Mr. Chen stock trades at Cyanotech, Stericycle, Abbott Laboratories, and Baxter International

Baxter International executives and stock owners

Baxter International executives and other stock owners filed with the SEC include:

Jose Almeida, Chairman of the Board, President, Chief Executive Officer
James Saccaro, Chief Financial Officer, Executive Vice President
Jeanne Mason, Senior Vice President – Human Resources
Brik Eyre, Senior Vice President, President – Americas
Giuseppe Accogli, Senior Vice President, President – Global Businesses
Sean Martin, Senior Vice President, General Counsel
Stephen Oesterle, Independent Director
James Gavin, Independent Director
Peter Hellman, Independent Director
Cathy Smith, Independent Director
John Forsyth, Independent Director
Michael Mahoney, Independent Director
Thomas Chen, Independent Director
Thomas Stallkamp, Lead Independent Director
Albert Stroucken, Independent Director
Clare Trachtman, Vice President, Investor Relations
Amy Wendell, Independent Director
Patricia Morrison, Independent Director
Scott Pleau, Senior Vice President – Operations
Andrew Frye, Senior Vice President and President, APAC
Cristiano Franzi, Senior Vice President and President, EMEA
Brian Stevens, Senior Vice President, Chief Accounting Officer, Controller
David P. Scharf, Corporate Vice President
Kees J Storm, Director
Marcus Schabacker, CVP, Chief Scientific Officer
Robert Felicelli, CVP, Quality
Carole J Uhrich, Director
Paul Vibert, CVP, International
Caroline Karp, CVP, Controller
Point Llc Loeb Daniel S Third,
Jacqueline Kunzler, SVP, Chief Quality Officer
Thomas J Jr Sabatino, Senior Vice President
Yuan Chia Pei, Director
Cheryl L White, Corporate Vice President
Joy A Amundson, Corporate Vice President
Jill M Schaaf, CVP, Renal
Harry M Jansen Jr Kraemer, Chairman and
Robert J. Hombach, Corporate Vice President & CFO
James E Utts, Corporate Vice President
Uma Chowdhry, Director
Peter J Arduini, Corporate Vice President
Bruce Mc Gillivray, Corporate Vice President
Sebastian J Bufalino, Corporate Vice President
Jean Luc Butel, Corporate Vice President
James M Gatling, Corporate Vice President
John C Moon, Corporate Vice President
Salto Carlos Del, Senior Vice President
Wayne T Hockmeyer, Director
Joseph B Martin, Director
Michael J Baughman, Corporate Vice President
Steven J Meyer, Treasurer
Michael J Tucker, Senior Vice President
James R Hurley, Corporate Vice President
Monroe E Trout, Director
Thomas Fang Tyan Chen, Director
Nevelle J Jeharajah, Corporate Vice President
Robert M Davis, Corp. VP, CFO and Treasurer
Jan Stern Reed, Corporate Secretary
Thomas H Glanzmann, Senior Vice President
Walter E Boomer, Director
Gail D Fosler, Director
Phillip L. Batchelor, Corporate Vice President
Karenann K Terrell, Corporate Vice President
Robert L Jr Parkinson, Chairman of the Board and
Karen J May, Corporate Vice President
Timothy P Lawrence, CVP, Operations
Blake E Devitt, Director
John J Greisch, Senior Vice President & CFO
Munib Islam, Director
Gregory P Young, Corporate Vice President
Susan R Lichtenstein, Corporate Vice President,
Lawrence T Gibbons, Corporate Vice President
David F Drohan, Senior Vice President
Fred L Turner, Director
Norbert G Riedel, Corporate Vice President
Brian P Anderson, Senior Vice President
Ludwig Hantson, Corporate Vice President

Thomas Chen Net Worth